Drug A (Blinded Drug)
HP-00116510
Phase 1 small_molecule on_hold
Quick answer
Drug A (Blinded Drug) for Opioid Use Disorder is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opioid Use Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- on_hold